Illness	Number of cases
Pneumonia organism unspecified - Bronchopneumonia unspecified organism (J18.0)	344
Left ventricular failure unspecified (I50.14)	342
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	322
Atrial fibrillation and flutter (I48.1)	245
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	179
Volume depletion (E86)	177
Left ventricular failure unspecified (I50.13)	156
(I21.40)	127
Syncope and collapse (R55)	127
Other forms of angina pectoris (I20.8)	122

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	1.460
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	1.274
(9-984.7)	1.095
Examination of the left side of the heart with a tube (catheter) inserted into the heart via an artery (1-275.0)	948
Ultrasound of the heart (echocardiography) through the oesophagus - TEE (3-052)	738
(9-984.8)	727
Measurement of the air remaining in the lungs after normal expiration, using the helium dilution method (1-713)	432
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	429
Treatment of the heart and/or the coronary arteries with access through a tube (catheter) along the blood vessels (8-837.00)	379
Treatment of cardiac arrhythmias with electric shocks - defibrillation (8-640.0)	368

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Asthma bronchiale

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ06
CQ31
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
177	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
117	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
80	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)	In Zusammenarbeit mit dem Universitätsklinikum Hamburg Eppendorf UKE und dem Universitätsklinikum Schleswig-Holstein - Campus Kiel.
Participation in multi-centre Phase I/II studies	Phase II: CIRCULATE (AIO-KRK-0217) Colon-Ca., randomisierte Doppelblindstudie zum Vergleich von Wirksamkeit, Pharmakokinetik, Sicherheit u. Immunogenität zwischen ABP 234+Keytruda® (Pembrolizumab) bei Pat. mit fortgeschrittenem/metastasiertem nicht-plattenepithelialem nicht-kleinzelligem Lungenkrebs
Project-related cooperation with colleges and universities	Hochschulstandort Neumünster
Editors of scientific journals/textbooks
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Participation in multi-centre phase III/IV studies	Phase III: FIRE-9-PORT/AIO, metastasiertes Kolorektal-Ca., Phase IV: INGA–fortgeschrittenes/metastasiertes Adeno-Ca. Magen, AEG/Ösophagus, FINN-NSCLC,Multizentrische Beobachtungsstudie zur Beurteilung d. Ergebnisse von Durvalumab-basierten Therapien bei hepatobiliären Krebserkrankungen, MMML-Predict
Lectureships / teaching posts at colleges and universities
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB10	Midwife (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB09	Speech therapist (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB07	Surgical technical assistant (m/f)
HB15	Anaesthesia technical assistant (m/f)
HB19	Nursing professionals	65 Ausbildungsplätze
HB17	Auxiliary nurse (m/f)	25 Ausbildungsplätze
HB03	Physical therapist / physiotherapist (m/f)	Absolvierung des obligatorischen Praktikums im FEK.
HB06	Occupational therapist (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB05	Medical technical radiology assistant (MTRA) (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB12	Medical technical laboratory assistant (MTLA) (m/f)	Absolvierung des obligatorischen Praktikums im FEK
HB16	Dietician (m/f)	Absolvierung des obligatorischen Praktikums im FEK